An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.
about
Rational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations.Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide StrategyThe Membrane-Proximal Region of C-C Chemokine Receptor Type 5 Participates in the Infection of HIV-1.Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.Nonneutralizing Antibodies Induced by the HIV-1 gp41 NHR Domain Gain Neutralizing Activity in the Presence of the HIV Fusion Inhibitor Enfuvirtide: a Potential Therapeutic Vaccine Strategy.Site-specific Isopeptide Bridge Tethering of Chimeric gp41 N-terminal Heptad Repeat Helical Trimers for the Treatment of HIV-1 Infection.Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime.Adding an Artificial Tail-Anchor to a Peptide-Based HIV-1 Fusion Inhibitor for Improvement of Its Potency and Resistance Profile.An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications.
P2860
Q27315206-B8A55345-5B9C-495B-999C-3C3F9F0B3B41Q30661709-394B797C-DD51-4B06-9DA2-370D50D4DF31Q33595068-CDF40A59-25EB-4C7C-B8CC-B6B76C4DFC3DQ34495644-147DDB24-9E08-476A-A0D4-0F4628C25624Q34793125-83FABC9A-8CEB-42B1-B5C1-4EAFAA59CB57Q35745350-441FC564-1C6F-48F2-98FE-0E229838548DQ37209050-BDBCDFB0-69CD-418A-BED5-90872213059BQ37512905-D3C15D88-4C4E-41B6-8D1F-55F5755A8799Q38157419-2A9AD63E-1967-4967-B970-790CEE8497C7Q42247165-00B5DAED-19FF-4476-8A30-CEE6468645DAQ47383689-61295852-96A9-41B8-8188-9A8F5D014E31Q55237287-C3B7EF42-6050-4B8F-8042-13BEF141CAC0
P2860
An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
An engineered HIV-1 gp41 trime ...... eloping anti-HIV microbicides.
@en
An engineered HIV-1 gp41 trime ...... eloping anti-HIV microbicides.
@nl
type
label
An engineered HIV-1 gp41 trime ...... eloping anti-HIV microbicides.
@en
An engineered HIV-1 gp41 trime ...... eloping anti-HIV microbicides.
@nl
prefLabel
An engineered HIV-1 gp41 trime ...... eloping anti-HIV microbicides.
@en
An engineered HIV-1 gp41 trime ...... eloping anti-HIV microbicides.
@nl
P2093
P2860
P356
P1476
An engineered HIV-1 gp41 trime ...... eloping anti-HIV microbicides.
@en
P2093
Xiaoxia Yu
Ying-Hua Chen
Zhifeng Lu
P2860
P304
P356
10.1093/JAC/DKT230
P407
P577
2013-06-21T00:00:00Z